Key Highlights
•
A new study in mice with Huntington’s disease shows that blocking a specific immune system protein, NLRP3, with a drug called MCC950 can significantly improve gut health, leading to softer stools and better digestion. This finding is important because it points to a potential new treatment strategy for the severe constipation and gut problems that often accompany Huntington’s disease, aiming to improve patients’ overall quality of life.
Source →
•
Researchers found that giving energy drinks to young female rats, both before and after they become pregnant, leads to noticeable problems with their social interactions and learning abilities. This suggests that early exposure to these highly caffeinated drinks could have lasting negative effects on brain development and behavior, raising concerns about their impact on young people.
Source →
•
A new report highlights the major challenges Latin America faces in dealing with dementia, including late diagnoses, limited access to specialized care and testing, and widespread stigma. Addressing these issues is critical as the region’s population ages rapidly, requiring tailored local strategies for prevention, treatment, and care to protect brain health.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
